Banque Transatlantique’s MediciNova MNOV Stock Holding History

Banque Transatlantique’s Portfolio MNOV Stock Details MNOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,850	Closed	-$2.62K	–	505
2026 Q1	$2.62K	Buy	+1,850	New	+$2.8K	﹤0.01%	412

Other funds holding MNOV

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Banque Transatlantique's MNOV Position: Q2 2026 in Review

Banque Transatlantique sold out of MediciNova (MNOV) in Q2 2026, closing a stake of 1,850 shares — an estimated $2.62K sold.

Banque Transatlantique first reported a position in MNOV in Q1 2026 and held it in 1 quarter. The position peaked at $2.62K in Q1 2026. 28 funds tracked by Wall St. Rank hold MNOV as of Q2 2026.

Banque Transatlantique reported no remaining MediciNova position as of Q2 2026 after selling out during the quarter.
Banque Transatlantique sold 1,850 MediciNova shares in Q2 2026, an estimated $2.62K.
Banque Transatlantique first reported a position in MediciNova in Q1 2026 and held it in 1 quarter.
Banque Transatlantique's MediciNova position peaked at $2.62K in Q1 2026.
28 funds tracked by Wall St. Rank held MediciNova as of Q2 2026.

Based on Banque Transatlantique's 13F filing for Q2 2026, filed 30 Jul 2026.